case report aspiration glp-1 receptor agonist anesthesia 2023 Managing patients taking glucagon-like peptide-1 American Society of Anesthesiologists Consensus-Based

GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health

Obesity management: Used widely for weight loss, even in non-diabetic individuals

Learn how GLP-1s can positively impact your wellness journey.

FRIDAY, Feb

In November 2025, the Trump administration announced landmark agreements with Eli Lilly and Novo Nordisk reducing the monthly price of GLP-1 weight-loss drugs from over $1,000 to as low as $245 for eligible patients

During the day, bone resorption is suppressed due to eating, while at night it i...